Healthy dietary interventions and lipoprotein (a) plasma levels: Results from the omni heart trial

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Haring, Bernhard ^a   Wyler Von Ballmoos, Moritz C ^b   Appel, Lawrence J ^c   Sacks, Frank M ^d  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C; APOLIPOPROTEIN E; CARBOHYDRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; CARBOHYDRATE DIET; EDIBLE OIL; LIPOPROTEIN A; PROTEIN INTAKE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; GLYCEMIC INDEX; HUMAN; LIPOPROTEIN BLOOD LEVEL; MACRONUTRIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SECONDARY ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; CARBOHYDRATE DIET; CLINICAL TRIAL; DIET; HEART DISEASES; METABOLISM;

ADULT; AGED; DIET; DIETARY CARBOHYDRATES; DIETARY FATS, UNSATURATED; DIETARY PROTEINS; FEMALE; HEART DISEASES; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED;

EID: 84918559521     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114859     Document Type: Article

References (34)

1. Frank S, Durovic S, Kostner GM (1996) The assembly of lipoprotein Lp(a). Eur J Clin Invest 26: 109-114.
2. Kostner GM, Wo X, Frank S, Kostner K, Zimmermann R, et al. (1997) Metabolism of Lp(a): assembly and excretion. Clin Genet 52: 347-354.
3. Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, et al. (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302: 412-423.
4. Genser B, Dias KC, Siekmeier R, Stojakovic T, Grammer T, et al. (2011) Lipoprotein (a) and risk of cardiovascular disease-a systematic review and meta analysis of prospective studies. Clin Lab 57: 143-156.
5. Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, et al. (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31: 2844-2853.
6. Ohira T, Schreiner PJ, Morrisett JD, Chambless LE, Rosamond WD, et al. (2006) Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 37: 1407-1412.
7. Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H (1996) Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci 33: 495-543.
8. Krempler F, Kostner GM, Bolzano K, Sandhofer F (1980) Turnover of lipoprotein (a) in man. J Clin Invest 65: 1483-1490.
9. Su W, Campos H, Judge H, Walsh BW, Sacks FM (1998) Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab 83: 3267-3276.
10. Boomsma DI, Kaptein A, Kempen HJ, Gevers Leuven JA, Princen HM (1993) Lipoprotein(a): relation to other risk factors and genetic heritability. Results from a Dutch parent-twin study. Atherosclerosis 99: 23-33.
11. Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG (2008) Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 117: 176-184.
12. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301: 2331-2339.
13. Lanktree MB, Anand SS, Yusuf S, Hegele RA (2010) Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ Cardiovasc Genet 3: 39-46.
14. Banerjee D, Wong EC, Shin J, Fortmann SP, Palaniappan L (2011) Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients. J Lipids 2011: 291954.
15. Seed M, O'Connor B, Perombelon N, O'Donnell M, Reaveley D, et al. (1993) The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis 101: 61-68.
16. Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, et al. (1998) Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 18: 441-449.
17. Shin MJ, Blanche PJ, Rawlings RS, Fernstrom HS, Krauss RM (2007) Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins. Am J Clin Nutr 85: 1527-1532.
18. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, et al. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76: 365-372.
19. Meinertz H, Nilausen K, Hilden J (2002) Alcohol-extracted, but not intact, dietary soy protein lowers lipoprotein(a) markedly. Arterioscler Thromb Vasc Biol 22: 312-316.
20. Nilausen K, Meinertz H (1999) Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein. Am J Clin Nutr 69: 419-425.
21. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, et al. (2006) Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113: 1034-1044.
22. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, et al. (2001) Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 86: 3053-3060.
23. Carey VJ, Bishop L, Charleston J, Conlin P, Erlinger T, et al. (2005) Rationale and design of the Optimal Macro-Nutrient Intake Heart Trial to Prevent Heart Disease (OMNI-Heart). Clin Trials 2: 529-537.
24. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, et al. (2005) Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294: 2455-2464.
25. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, et al. (2001) Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344: 3-10.
26. Furtado JD, Campos H, Sumner AE, Appel LJ, Carey VJ, et al. (2010) Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial. Am J Clin Nutr 92: 714-722.
27. Berglund L, Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, et al. (2007) Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr 86: 1611-1620.
28. Brousseau ME, Ordovas JM, Nicolosi RJ, Schaefer EJ (1994) Effects of dietary fat saturation on plasma lipoprotein(a) and hepatic apolipoprotein(a) mRNA concentrations in cynomolgus monkeys. Atherosclerosis 106: 109-118.
29. Brousseau ME, Ordovas JM, Osada J, Fasulo J, Robins SJ, et al. (1995) Dietary monounsaturated and polyunsaturated fatty acids are comparable in their effects on hepatic apolipoprotein mRNA abundance and liver lipid concentrations when substituted for saturated fatty acids in cynomolgus monkeys. J Nutr 125: 425-436.
30. Tholstrup T, Marckmann P, Vessby B, Sandstrom B (1995) Effect of fats high in individual saturated fatty acids on plasma lipoprotein[a] levels in young healthy men. J Lipid Res 36: 1447-1452.
31. Nestel P, Noakes M, Belling B, McArthur R, Clifton P, et al. (1992) Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 33: 1029-1036.
32. Crouse JR, 3rd, Morgan T, Terry JG, Ellis J, Vitolins M, et al. (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159: 2070-2076.
33. Rader DJ, Cain W, Zech LA, Usher D, Brewer HB, Jr. (1993) Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest 91: 443-447.
34. Kostner KM, Kostner GM (2004) Factors affecting plasma lipoprotein(a) levels: role of hormones and other nongenetic factors. Semin Vasc Med 4: 211-214.